SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-028981
Filing Date
2019-05-13
Accepted
2019-05-13 17:08:47
Documents
53
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-9569_110q.htm 10-Q 463607
2 EX-31.1 a19-9569_1ex31d1.htm EX-31.1 9389
3 EX-31.2 a19-9569_1ex31d2.htm EX-31.2 9622
4 EX-32.1 a19-9569_1ex32d1.htm EX-32.1 5026
5 EX-32.2 a19-9569_1ex32d2.htm EX-32.2 5058
  Complete submission text file 0001104659-19-028981.txt   2427727

Data Files

Seq Description Document Type Size
6 EX-101.INS cycn-20190331.xml EX-101.INS 430301
7 EX-101.SCH cycn-20190331.xsd EX-101.SCH 29198
8 EX-101.CAL cycn-20190331_cal.xml EX-101.CAL 22453
9 EX-101.DEF cycn-20190331_def.xml EX-101.DEF 79806
10 EX-101.LAB cycn-20190331_lab.xml EX-101.LAB 206112
11 EX-101.PRE cycn-20190331_pre.xml EX-101.PRE 176034
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 19819283
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences